『Femtech Health Podcast』のカバーアート

Femtech Health Podcast

Femtech Health Podcast

著者： Sheree Dibiase
無料で聴く

Femtech and women's health podcast. We talk to leading experts in endometriosis, prenatal postpartum, pelvic floor, biotech and more. Join us weekly for conversations your OBGYN didn't even know existed.© 2026 Sheree Dibiase 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Why 90% of Couples Skip the Most Important Step Before Getting Pregnant (And How to Fix It)

    Why 90% of Couples Skip the Most Important Step Before Getting Pregnant (And How to Fix It)
    2026/08/31

    In this episode, we're joined by Ronit Menashe, co-founder of WeNatal. Ronit has a background in functional medicine and wellness, having previously worked at Nike.

    Ronit shares her personal journey through fertility challenges, including a miscarriage that led her to discover the importance of both partners' health in the fertility equation. She emphasizes the concept of "trimester zero," a crucial three-month period before conception where both partners can optimize their health through lifestyle changes and nutrition.

    Our discussion covers the significance of epigenetics, the impact of male fertility on pregnancy outcomes, and the importance of education and preparation for couples looking to conceive.

    Have questions? Drop them in the comments below.

    Follow Ronit Menashe and WeNatal
    https://www.instagram.com/ronitmenashe_/
    https://wenatal.com/

    Learn more at LakeCityPT.com
    Download the Pelvic Floor Pro app for guided pelvic health programs
    続きを読む 一部表示
    1 時間
  • Breast Exams at Home: How AI Expands Access Beyond Traditional Screening

    Breast Exams at Home: How AI Expands Access Beyond Traditional Screening
    2026/02/16

    Breast cancer screening fails most often where access is constrained: limited appointments, geographic gaps, dense breast tissue, and reliance on self-exams that depend entirely on human touch. Awareness alone doesn’t close those gaps.

    In this episode, Dr. Karny Ilan, co-founder and CEO of Feminai, shares how physician-led product design, multidisciplinary collaboration, and rigorous clinical trials shaped a new model for breast screening access. The conversation explores a shift in how breast health is managed—from episodic screening to continuous, individualized monitoring. Rather than relying on infrequent appointments alone, it examines tools designed to track changes over time, at home, while remaining connected to clinical decision-making.


    Timestamps

    • (00:11) Breast cancer risk shaped by genetics and lived exposure
    • (08:37) Limits of traditional self-breast exams
    • (09:09) Personal experience shaping breast health urgency
    • (10:15) How at-home breast scanning detects change over time
    • (12:42) Designing screening tools for dense breast tissue
    • (17:03) Addressing breast size, shape, and post-surgical variation
    • (18:31) Clinical trials revealing real-world usability gaps
    • (20:13) Why ease of use affects screening reliability
    • (29:29) Access gaps amplified by pandemic-era screening delays
    • (38:09) Broad inclusion across age, risk, and body types


    Guest Bio

    Dr. Karny Ilan — Co-Founder and CEO, Feminai
    Dr. Karny Ilan is a general surgery resident at Sheba Medical Center and the co-founder and CEO of Feminai, a breast health company developing an AI-enabled disposable wearable patch and app for at-home breast exams. With a strong family history of breast cancer, she brings clinical experience and patient-centered design to building scalable screening tools that expand access and personalization.
    LinkedIn: https://www.linkedin.com/in/karny-ilan/

    Key Points

    • Access constraints drive missed detection: Feminai targets screening gaps caused by geography, capacity, and avoidance.
    • Physician-led design builds trust: Clinical credibility accelerated adoption with providers and investors.
    • Dense breast tissue is a priority use case: The technology is designed to perform well where mammography often struggles.
    • Personalized baselines change detection logic: Each scan is compared against the user’s own prior data.
    • Usability directly affects accuracy: Instructions, fit, and behavior shape downstream AI performance.


    Deep Dives

    1. At-home breast exams as infrastructure

    • Designed for frequent, low-friction use
    • Complements rather than replaces imaging

    2. Patch and app workflow

    • Risk stratification via medical questionnaire
    • Bluetooth-enabled scan uploads to secure cloud
    • AI analysis with physician review

    3. Designing for every body

    • Stretch materials accommodate size variation
    • Dense tissue explicitly accounted for
    • Additional sizes planned as rollout expands

    4. Clinical trials beyond performance metrics

    • Usability drove multiple design iterations
    • Instruction format affected adherence
    • Shape changes required algorithm updates

    5. Personalized longitudinal tracking

    • Each woman compared only to herself
    • Changes flagged based on deviation, not population averages

    6. Leadership and multidisciplinary teams

    • Engineers exposed to clinical sites
    • Patient stories shared to reinforce mission
    • Stability in leadership communication protected execution


    Links & References

    • Breast cancer screening beyond mammography (Mayo Clinic): https://www.mayoclinic.org/tests-procedures/mammogram/in-depth/breast-cancer/art-20047233
    • Breast cancer screening recommendations (USPSTF): https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
    続きを読む 一部表示
    45 分
  • The Cost of Delay: Why Midlife Health Breaks Down and What It Takes to Build a Sustainable Routine

    The Cost of Delay: Why Midlife Health Breaks Down and What It Takes to Build a Sustainable Routine
    2026/02/09
    Midlife health decisions rarely fail because women “don’t know what to do.” They fail because the stakes change overnight, the calendar stays overloaded, and the system you used to rely on stops working.This conversation sits at the intersection of two realities: breast cancer can show up even without family history, and the perimenopause to menopause transition forces a new level of precision around hormones, bone health, fatigue, and what you put on your skin.In this episode, Sally Mueller, co-founder of Womaness, speak candidly from lived experience—diagnosis timelines, treatment tradeoffs, dense breast screening gaps, and the unglamorous but decisive habits that actually keep women on track.Timestamps(03:16) Following instincts as an early prevention strategy (11:18) Clean, hormone-free formulations and long-term exposure risk (12:58) Hereditary versus environmental drivers of breast cancer (20:20) Dense breast tissue and proactive screening strategies (27:31) Vitamin D deficiency and systemic fatigue signals (28:49) Supplement consistency versus reactive use (32:32) Why steady supplementation outperforms short-term fixes (36:18) Bone health through impact, resistance, and movement variety (40:07) Exercise variation as a stimulus for bone remodeling (41:47) Treating exercise like a non-negotiable meeting Guest BioSally Mueller — Co-Founder and CEO, WomanessSally Mueller is the co-founder of Womaness, a women’s wellness brand focused on perimenopause and menopause solutions across skin, body, supplements, and sexual wellness.LinkedIn: https://www.linkedin.com/in/sally-mueller/Key PointsMidlife health breakdown is often a systems failure, not a motivation problem: Delayed screenings, inconsistent supplements, and deprioritized movement compound risk over time.Early detection depends on follow-through, not awareness: Dense breast tissue, hormone shifts, and missed baselines create blind spots when care is delayed.Consistency beats intensity in supplements and exercise: Vitamin D, bone-loading movement, and simple routines outperform sporadic “health resets.”Clean inputs matter more after cancer, but should start earlier: What women put on and in their bodies becomes more consequential during hormonal transition.Exercise functions as prevention infrastructure, not lifestyle garnish: Impact, resistance, and aerobic movement materially affect recurrence risk, bone density, and fatigue.Deep DivesDelayed care as a compounding risk factorMissed appointments increase exposure windowsDelays often happen during peak hormonal volatilityDense breast tissue and the screening gapMammograms alone can miss early signalsUltrasound and MRI baselines improve detectionVitamin D deficiency as a hidden performance drainFatigue and joint pain can signal depletionWinter and low sun accelerate declineSupplement discipline versus reactive useInconsistent intake reduces benefitFewer supplements taken regularly outperform complex stacksBone health beyond medicationImpact and resistance stimulate bone remodelingMovement variety matters more than volumeExercise as a protective interventionAerobic activity reduces systemic disease riskStrength work supports bone and joint resilienceClean formulations and cumulative exposureHormone-free products reduce added loadTransparency matters more during midlife transitionsWhy midlife routines collapse firstCaregiving, careers, and stress convergeHealth behaviors are usually the first to dropTreating exercise like a meetingScheduled movement increases adherenceNon-negotiable time blocks protect consistencyPrevention as an operating modelMidlife health requires durable systemsShort-term fixes fail under long timelinesLinks & ReferencesBreast cancer screening beyond mammography (Mayo Clinic): https://www.mayoclinic.org/tests-procedures/mammogram/in-depth/breast-cancer/art-20047233Vitamin D deficiency, symptoms, and testing (National Institutes of Health): https://ods.od.nih.gov/factsheets/VitaminD-Consumer/Exercise and bone health in midlife and beyond (International Osteoporosis Foundation): https://www.osteoporosis.foundation/health-professionals/prevention/exercise
    続きを読む 一部表示
    55 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません